The second webinar on the "Right to innovation: understanding personalised prevention in Europe", realized in the framework of the EU-funded project PROPFHET, took place on 10 of March 2026. Fine modulo More than 90 participants attended, with active discussions around innovation, personalised prevention, and the role of citizens and patients in making these approaches a reality.
A few key takeaways messages among others:
• Personalised prevention: better understanding of what it means in practice and how it differs from traditional prevention, with strong appreciation for concrete examples (BRCA, cardiovascular risk, pharmacogenomics)
• Right to innovation: innovation should be accessible, understandable, and beneficial for all citizens, not only for a few
• Citizens’ role: strong emphasis on awareness, trust, and engagement as essential conditions for implementation
Participants also raised relevant questions, particularly on:
• How to access personalised prevention in practice and where to start
• The role of healthcare professionals and the level of awareness among doctors
• The importance of psychological support and trust when dealing with risk information
Here you can watch the recording, and below you can download the speakers' presentations (by clicking on their names).
Right to innovation. Understanding personalised prevention in Europe
Online information session
10 March 2026 – 15:00–16:30 CET
Daniela Quaggia (Cittadinanzattiva – Active Citizenship Network)
Opening remarks and introduction to the “Right to Innovation” and the role of civic organisations
Sara Farina (Università Cattolica del Sacro Cuore)
What personalised prevention is, how it differs from traditional prevention, how it works in practice, with real-life examples and introduction to PROPHET
Tamara Milagre (Founder, EVITA)
Personal story, activities of the association, and patient perspective on personalised prevention
Closing remarks and next steps
Towards the next European Patients’ Rights Day, dedicated to PROPHET and personalised prevention in the EU and Italy
